Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Vanda Pharmaceuticals Inc.    VNDA

Delayed Quote. Delayed  - 09/27 10:00:00 pm
16.83 USD   -1.29%
09/24 VANDA PHARMACEU : Prepares to Explore a Sale – Sources
09/17 VANDA PHARMACEU : USPTO Dismisses Petition for Inter Partes Review o..
08/31 VANDA PHARMACEU : USPTO Dismisses Petition for Inter Partes Review o..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Upcoming events on VANDA PHARMACEUTICALS INC.
11/01/16 Q3 2016 Earnings Release (Projected)
02/14/17 FY 2016 Earnings Release (Projected)
05/11/17 Q1 2017 Earnings Release (Projected)
08/02/17 Interim 2017 Earnings Release (Projected)
Past events on VANDA PHARMACEUTICALS INC.
07/27/16 | 10:30pm Interim 2016 Earnings Call
07/27/16 | 10:01pm Interim 2016 Earnings Release
06/21/16 | 09:30pm JMP Securities Life Sciences Health Care Conference
06/16/16 Annual General Meeting
Upcoming sector events for VANDA PHARMACEUTICALS INC.
09/28/16 | 07:35pm ALNYLAM PHARMACEUTICALS, INC. : Leerink Partners Rare Disease & Immuno Oncology Roundtable Conference
09/28/16 | 09:40pm VERTEX PHARMACEUTICALS INCORPORATED : Leerink Partners Rare Disease & Immuno Oncology Roundtable Conference
09/29/16 | 07:00pm TESARO INC : Leerink Partners Rare Disease & Immuno Oncology Roundtable Conference
09/29/16 | 09:45pm INCYTE CORPORATION : Leerink Partners Rare Disease & Immuno Oncology Roundtable Conference
Annual publications
Previous yearNext Year
Annual results2013201420152016 (e)2017 (e)
Sales
Million $
Released
Forecast
Spread
33,9
34,0
-0,28%
50,2
65,7
-24%
110
109
0,44%

147

184
Operating income (EBITDA)
Million $
Released
Forecast
Spread
-18,5
-15,0
-23%
-54,8
-54,0
-1,4%






Operating profit (EBIT)
Million $
Released
Forecast
Spread
-20,4
-17,9
-14%
-57,6
-57,4
-0,36%
-40,2
-31,8
-26%

-31,2

-1,08
Pre-Tax Profit (EBT)
Million $
Released
Forecast
Spread
-20,3









Net income
Million $
Released
Forecast
Spread
-20,3
-18,5
-9,5%
20,2
-57,8
135%
-39,9
-33,9
-18%

-25,9

6,23
EPS
 $
Released
Forecast
Spread
-0,67
-0,62
-8,5%
0,55
-1,63
134%
-0,94
-0,77
-22%

-0,63

-0,11
Announcement Date02/13/201402/19/201502/10/2016

Quarterly / Semiannualy publications
Previous yearPrevious periodNext periodNext Year
Quarterly resultsQ4
2015
Q1
2016
Q2
2016
Q3
2016 (e)
Q4
2016 (e)
Sales
Million $
Released
Forecast
Spread
31,8
31,3
1,6%
33,3
32,6
2,1%
36,0
35,8
0,71%

38,0

39,6
Operating income (EBITDA)
 
Released
Forecast
Spread










Operating profit (EBIT)
Million $
Released
Forecast
Spread
-14,9
-11,3
-31%
-12,5
-11,9
-4,8%
-4,79
-9,18
48%

-8,06

-6,14
Pre-Tax Profit (EBT)
 
Released
Forecast
Spread










Net income
Million $
Released
Forecast
Spread
-14,8
-11,2
-32%
-12,4
-10,5
-18%
-4,62
-9,11
49%

-7,87

-5,98
EPS
 $
Released
Forecast
Spread
-0,35
-0,26
-33%
-0,29
-0,24
-19%
-0,11
-0,23
51%

-0,15

-0,09
Announcement Date02/10/201605/04/201607/27/2016

© 2016 Thomson Reuters
© 2016 Factset
Advertisement
Net sales - Rate of surprise
Operating profit - Rate of surprise
EPS - Rate of surprise